Latest news with #BrainCancerAwarenessMonth
28-05-2025
- Health
9-year-old fights brain cancer with magic in her heart
May is Brain Cancer Awareness Month, and ABC News' Kyra Phillips follows Kasey Zachmann and her years-long battle with the disease. May 27, 2025
Ottawa Citizen
14-05-2025
- Health
- Ottawa Citizen
The Dwayne Andrews Glioblastoma Research Grant Awarded to Dr. Jeremy Brown, Dalhousie University
Article content TORONTO, May 14, 2025 (GLOBE NEWSWIRE) — Brain Cancer Canada is proud to announce The Dwayne Andrews Glioblastoma Research Grant of $85,000 awarded to Dr. Jeremy Brown at Dalhousie University for his project, 'Clinical Testing of a High-Resolution Ultrasound Endoscope for Guiding Brain Tumour Resection.' This innovative initiative aims to improve surgical outcomes for patients diagnosed with glioblastoma multiforme (GBM), one of the most aggressive and fatal brain cancers. Article content Article content Article content GBM carries a one-year survival rate of just 25%, and surgical resection remains the primary standard of care. Studies have consistently shown that more accurate tumour removal during surgery is associated with longer patient survival. However, imaging technologies currently available to guide surgeons during operations are limited in both precision and practicality. Article content To address this critical need, Dr. Brown's team has developed a miniature, pencil-sized ultrasound imaging probe capable of visualizing tumour tissue in real time during surgery. This device is distinguished not only by its compact size but also by its exceptionally high resolution, allowing it to detect tumour margins with remarkable accuracy. The project will clinically test the performance of this new technology by evaluating its ability to enhance tumour resection during brain surgery. Article content 'Our goal is to make precision ultrasound imaging during neurosurgery a clinical standard. By increasing the accuracy of brain tumour resection, we can extended survival and improve quality of life for those battling glioblastoma,' says Dr. Brown. 'This generous funding from Brain Cancer Canada represents a crucial step forward in our mission to significantly improve outcomes for patients facing this aggressive form of brain cancer.' Article content Article content The Dwayne Andrews Glioblastoma Research Grant has been made possible through the generous support of the Auto|One Group and The Andrews Family. Article content Kevin Andrews, President & CEO of Auto|One Group, experienced the loss of his brother Dwayne Andrews to Glioblastoma in 2020, less than two years after his diagnosis. 'It is both a personal honour and a privilege on behalf of Auto|One Group to partner with BCC in supporting cutting-edge brain cancer research in memory of my brother,' says Kevin. 'Dwayne's strength and spirit continue to inspire me every day. Collaborating with Dr. Brown at Dalhousie University, our family's alma mater, holds deep meaning for us. This vital research represents hope and is paving the way for innovative treatment options for families impacted by this devastating disease: Everyone deserves the chance for survival — a chance my brother never had.' Article content This announcement is part of a series of six grants announced during Brain Cancer Awareness Month. Brain Cancer Canada remains committed to driving forward innovative solutions and pursuing hope for those affected by brain cancer by investing in critically needed research.
Hamilton Spectator
14-05-2025
- Health
- Hamilton Spectator
The Dwayne Andrews Glioblastoma Research Grant Awarded to Dr. Jeremy Brown, Dalhousie University
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) — Brain Cancer Canada is proud to announce The Dwayne Andrews Glioblastoma Research Grant of $85,000 awarded to Dr. Jeremy Brown at Dalhousie University for his project, 'Clinical Testing of a High-Resolution Ultrasound Endoscope for Guiding Brain Tumour Resection.' This innovative initiative aims to improve surgical outcomes for patients diagnosed with glioblastoma multiforme (GBM), one of the most aggressive and fatal brain cancers. GBM carries a one-year survival rate of just 25%, and surgical resection remains the primary standard of care. Studies have consistently shown that more accurate tumour removal during surgery is associated with longer patient survival. However, imaging technologies currently available to guide surgeons during operations are limited in both precision and practicality. To address this critical need, Dr. Brown's team has developed a miniature, pencil-sized ultrasound imaging probe capable of visualizing tumour tissue in real time during surgery. This device is distinguished not only by its compact size but also by its exceptionally high resolution, allowing it to detect tumour margins with remarkable accuracy. The project will clinically test the performance of this new technology by evaluating its ability to enhance tumour resection during brain surgery. 'Our goal is to make precision ultrasound imaging during neurosurgery a clinical standard. By increasing the accuracy of brain tumour resection, we can extended survival and improve quality of life for those battling glioblastoma,' says Dr. Brown. 'This generous funding from Brain Cancer Canada represents a crucial step forward in our mission to significantly improve outcomes for patients facing this aggressive form of brain cancer.' The Dwayne Andrews Glioblastoma Research Grant has been made possible through the generous support of the Auto|One Group and The Andrews Family. Kevin Andrews, President & CEO of Auto|One Group, experienced the loss of his brother Dwayne Andrews to Glioblastoma in 2020, less than two years after his diagnosis. 'It is both a personal honour and a privilege on behalf of Auto|One Group to partner with BCC in supporting cutting-edge brain cancer research in memory of my brother,' says Kevin . 'Dwayne's strength and spirit continue to inspire me every day. Collaborating with Dr. Brown at Dalhousie University, our family's alma mater, holds deep meaning for us. This vital research represents hope and is paving the way for innovative treatment options for families impacted by this devastating disease: Everyone deserves the chance for survival — a chance my brother never had.' This announcement is part of a series of six grants announced during Brain Cancer Awareness Month. Brain Cancer Canada remains committed to driving forward innovative solutions and pursuing hope for those affected by brain cancer by investing in critically needed research. About Brain Cancer Canada Brain Cancer Canada is a national charity dedicated to improving the lives of those affected by primary malignant brain tumors by funding research, advocating for effective treatment options, and investing in neurosurgical technologies. Since 2015, Brain Cancer Canada has directed more than 2.4 million dollars to brain cancer research, to 25 projects at nine institutions, research centres, and hospitals across Canada. More Information For more detail about this and other research initiatives supported by Brain Cancer Canada, please visit Media Contact: angela@ 1-855-375-1381
Associated Press
08-05-2025
- Health
- Associated Press
The End Brain Cancer Initiative Hosts Free GBM Patient/Caregiver Educational Webinar for Brain Cancer Awareness Month
REDMOND, WA, UNITED STATES, May 8, 2025 / / -- Contact: Dellann Elliott Mydland, 425-785-8489, [email protected] The End Brain Cancer Initiative Hosts Free GBM Patient/Caregiver Educational Webinar for Brain Cancer Awareness Month In honor of Brain Cancer Awareness Month, the End Brain Cancer Initiative (EBCI) is hosting a free educational webinar for patients and caregivers on Friday, May 16, 2025 at 11 AM Pacific Time. The Know All Your Treatment Options (KAYTO) annual online event is designed specifically for members of the brain tumor, brain cancer, and metastasized brain tumor community to 'DIRECTLY CONNECT' with top specialists, doctors, and researchers in the field. Attendees will hear about advanced and FDA approved treatment options, clinical trials, devices, diagnostics, and more. The event is free to attend, but pre- registration is required. Registration is open at Thank you to presenting sponsors Telix Pharmaceuticals and Novocure for making this free patient disease educational event possible. This year's keynote speakers are Dr. John de Groot and Dr. Javier Villanueva-Meyer from the University of California, San Francisco (UCSF). The doctors will share updates and challenges in the diagnosis and management of Glioblastoma (GBM), as well as the role for advanced PET imaging and why it is important to GBM treatment. About Telix Pharmaceuticals Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Visit for further information. About Novocure Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non- small cell lung cancer and pancreatic cancer. Visit for further information. About the End Brain Cancer Initiative To support/donate to the End Brain Cancer Initiative's increased access and health delivery for patients, mission, services and programs, please visit The End Brain Cancer Initiative (EBCI) is a 501(c)3 non-profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative at Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, [email protected] Dellann Elliott Mydland End Brain Cancer Initiative +1 425-785-8489 [email protected] Visit us on social media: LinkedIn Instagram Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
08-05-2025
- Health
- Yahoo
Aussie family 'overwhelmed' by incredible $120,000 windfall after tragic twist with baby girl
Just days after celebrating her first birthday, little Audrey's world was turned upside down by a devastating diagnosis. The young family's world changed when, on the first day of Brain Cancer Awareness Month, Audrey was diagnosed with the devastating disease. Source: GoFundMe Surrounded by friends, family and her adoring parents Maddie and Sam, little Audrey Tunks recently celebrated her first birthday. Guests at the party couldn't help but ask Maddie, "Does she ever cry?" — a reflection of Audrey's happy nature and content spirit. But on May 1, the first day of Global Brain Cancer Awareness Month, the family's world changed. The "beautiful, vibrant" one-year-old was diagnosed with the devastating disease. Speaking to Yahoo News Australia, Maddie said after receiving advice that Audrey's head circumference had increased slightly during a Maternal and Child Health Nurse appointment (MCHN), she wasted no time in booking in a scan. ADVERTISEMENT Advertisement The family, from Melbourne, were then given the shocking news — Audrey had developed a rare and aggressive type of medulloblastoma, with multiple tumours found in her brain and spine. She has since undergone two brain surgeries, one of which lasted 12 hours. Another was taking place the morning Yahoo spoke to the family this week. With chemotherapy and more surgeries scheduled, Maddie said it will be some time before a treatment plan is finalised, as doctors first need to determine the specific type of medulloblastoma Audrey has. It's a crucial step, given the several subtypes of the disease, each with distinct genetic profiles and treatment responses. A rare and fast-growing type of brain cancer, medulloblastoma primarily affects children. It begins in the cerebellum, the part of the brain at the back of the skull that controls balance, coordination, and some motor functions. As a central nervous system tumour, it can spread to other areas of the brain and spinal cord through the cerebrospinal fluid. Maddie said the road to recovery is long and difficult, and treatment options are limited due to Audrey's age. But despite the overwhelming challenges, Audrey remains cheerful, strong and "ready to fight this". Audrey Tunks is described by her loved ones as 'beautiful, happy' and a 'fighter'. Source: GoFundMe Mum's desperate message to parents after daughter's crushing diagnosis While Maddie is still reeling from how quickly their world changed, she holds on to hope and is determined to raise awareness for other families facing the same devastating diagnosis. She encourages all parents to take MCHN appointments seriously, even if their child is seemingly healthy. ADVERTISEMENT Advertisement "I really would like to stress the importance of going," she told Yahoo. "I have so many friends who have babies, and so many of them go, 'Oh, my baby's happy, healthy. There's nothing developmentally going on. It's fine if I miss it'. "We had no reason to know that anything was going wrong, she was literally her happiest self. And if we hadn't gone to that appointment, we wouldn't have picked this up, because there were no signs. Had we not gone to that appointment, who knows how bigger the tumours would have grown, or how much more they would have metastasised." Parents Sam, left, and Maddie, right, with one-year-old Audrey. Source: GoFundMe To make matters more difficult, Maddie and Sam have another child Elliot who is also a toddler. Additionally, the young mum said it's not as though the family attend the hospital at intervals. "We haven't been in and out of the hospital," she said. "We've just been in". ADVERTISEMENT Advertisement "My partner and I continue to have very big moments of heartbreak, but we're trying to just stay hopeful at the same time. Trying to balance life with Elliot at home and Audrey in the hospital, you just can't be next to each other all the time, which is really hard for us." The emotional and financial strain on the family is immense, especially as both parents have stepped away from work. To support them, a fundraiser has been launched to help cover medical and daily expenses, as well as potential future treatments. Maddie says she's "incredibly overwhelmed" by the $120,000 already donated and thankful for the community support the family has received. "Because of the generosity, we've been given the most important gift in this world — time together as a family... away from work and to focus on our babies," she said, encouraging people to donate blood if they're able to, after Audrey required a full blood replacement during surgery. "Every type of cancer is shit. But this one is really, really bad," Maddie said. "It's brain cancer awareness month, so let's raise some awareness." Do you have a story tip? Email: newsroomau@ You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
